Blood Sugar News and Research

RSS

Blood sugar concentration, or glucose level, refers to the amount of glucose present in the blood of a human or animal. Normally, in mammals the blood glucose level is maintained at a reference range between about 3.6 and 5.8 mM (mmol/l). It is tightly regulated as a part of metabolic homeostasis.

Gum disease linked with diabetes

Gum disease and diabetes are chronic conditions that increase with age. The link between the two diseases goes both ways. It is thought that inflammation in the body is the connection- in fact, gum disease is the most common inflammatory disease.

14 Nov 2018

Addressing chronic diseases could save tens of billions of dollars in healthcare costs annually

As Americans head to the polls this coming Tuesday, a top issue for all voters is the rising cost of healthcare. A new report has found that addressing chronic diseases, and in particular diabetes, could save tens of billions of dollars in healthcare costs annually.

2 Nov 2018

Dogs trained to sniff out malaria

It is already known that dogs with their sharp noses can sniff out a host of human diseases including cancers.

31 Oct 2018

Natural protein may offer novel therapy to reverse disorders associated with metabolic syndrome

To the great surprise of cancer researchers, a protein they investigated for its possible role in cancer turned out to be a powerful regulator of metabolism.

29 Oct 2018

Getting right level of leptin may help protect cardiovascular health

Like that famous bowl of porridge, when leptin levels are "just right" they help protect our cardiovascular health, scientists say.

29 Oct 2018

Stroke 'mimics' and 'chameleons' can complicate accurate diagnoses

Stroke specialists often see conditions known as stroke "mimics" and "chameleons" that can complicate accurate diagnoses, Loyola Medicine neurologists report in the November 2018 issue of Neuroimaging Clinics of North America.

26 Oct 2018

Insulin discovery could improve treatments for diabetes

An international collaboration co-led by researchers at the Walter and Eliza Hall Institute has made a discovery that could make therapeutic insulins more effective by better mimicking the way insulin works in the body.

24 Oct 2018

Healthy candies for diabetic patients

The technology of making sweets has been worked out for more than months, experiments have led to the invention of exclusive flavors, which are not yet available on the confectionery market.

19 Oct 2018

Fat tissue could be a source of diabetes, shows new research

A new study by Australian researchers, out today, is challenging what we know about the causes of diabetes. The new research points to fat tissue as a source of disease, and widens our understanding beyond the traditional focus on liver and pancreas as the main culprits.

12 Oct 2018

Self-care polymers fibers recognize need for therapy

Drug-releasing textiles could, for instance, be used to treat skin wounds. Empa researchers are currently developing polymer fibers that can be equipped with drugs. The smart fibers recognize the need for therapy all by themselves and dose the active ingredients with precision and accuracy.

12 Oct 2018

Researchers streamline design of lab-on-a-chip devices to observe their inner workings

Microfluidic devices can take standard medical lab procedures and condenses each down to a microchip that can balance on top of a water bottle lid.

6 Oct 2018

Researchers discover previously unknown function of key component in the immune system

The complement proteins that circulate in our blood are an important part of our immune system. They help identify bacteria, viruses and other harmful organisms, making it easier for our white blood cells to find and neutralize dangerous microbes.

5 Oct 2018

Lilly, Boehringer Ingelheim present full results of cardiovascular outcome trial, CARMELINA

Boehringer Ingelheim and Eli Lilly and Company today presented the full results of the long-term cardiovascular outcome trial, CARMELINA®, which studied the impact of Trajenta® (linagliptin) on cardiovascular and kidney safety in adults with type 2 diabetes at high risk for heart and/or kidney disease.

5 Oct 2018

Tarragon and bitter melon supplements may be less helpful for women than men

Russian tarragon and bitter melon supplements may be less helpful for women than men when it comes to combating metabolic syndrome, whose symptoms include high blood sugar, high blood pressure and excess fat around the waist.

5 Oct 2018

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Berlin, Germany, and published in The Lancet, shows that the appetite-suppressant drug lorcaserin decreases risk of developing diabetes and increases the rates of remission of high blood sugar.

4 Oct 2018

Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction Study Group presented diabetes-related findings from CAMELLIA-TIMI 61, a clinical trial of overweight and obese patients designed to test lorcaserin, a weight loss drug manufactured by the trial's sponsor, Eisai Inc.

4 Oct 2018

Yo-yo dieting increases risk of heart attack and stroke, finds study

In the study, sudden changes in metabolic health parameters were associated with a raised risk of heart attacks, strokes and even early deaths.

4 Oct 2018

Blocking stress-responsive protein reduces loss of tumor suppressor gene in breast cancer

Over half of all breast cancers carry genetic defects in the p53 gene, a powerful tumor suppressor. Loss of this gene increases the risk of getting breast cancer and the resultant cancers become highly resistant to treatment.

4 Oct 2018

Closed-loop insulin delivery improves blood sugar control in type 1 diabetes

A study has shown that hybrid day-night closed-loop insulin delivery systems are the most effective way of controlling blood sugar levels in type 1 diabetes.

3 Oct 2018

Closed-loop insulin delivery system shows better results for blood sugar control in type 1 diabetes

New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Berlin, Germany, and published in The Lancet, shows that use of a hybrid day-night closed-loop insulin delivery system is better than sensor-augmented pump therapy for blood sugar control in poorly controlled type 1 diabetes.

3 Oct 2018

Blood Sugar News and Research

Further Reading

Gum disease linked with diabetes

Addressing chronic diseases could save tens of billions of dollars in healthcare costs annually

Dogs trained to sniff out malaria

Natural protein may offer novel therapy to reverse disorders associated with metabolic syndrome

Getting right level of leptin may help protect cardiovascular health

Stroke 'mimics' and 'chameleons' can complicate accurate diagnoses

Insulin discovery could improve treatments for diabetes

Healthy candies for diabetic patients

Fat tissue could be a source of diabetes, shows new research

Self-care polymers fibers recognize need for therapy

Researchers streamline design of lab-on-a-chip devices to observe their inner workings

Researchers discover previously unknown function of key component in the immune system

Lilly, Boehringer Ingelheim present full results of cardiovascular outcome trial, CARMELINA

Tarragon and bitter melon supplements may be less helpful for women than men

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

Yo-yo dieting increases risk of heart attack and stroke, finds study

Blocking stress-responsive protein reduces loss of tumor suppressor gene in breast cancer

Closed-loop insulin delivery improves blood sugar control in type 1 diabetes

Closed-loop insulin delivery system shows better results for blood sugar control in type 1 diabetes

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News